T. Rowe Price Investment Management
RXDX

T. Rowe Price Investment Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

T. Rowe Price Investment Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-868,006
Closed -$93.2M – 593
2023
Q1 		$93.2M Buy
868,006
+3,467
+0.4% +$372K 0.07% 270
2022
Q4 		$95.1M Buy
864,539
+457,288
+112% +$50.3M 0.07% 266
2022
Q3 		$24M Buy
+407,251
New +$24M 0.02% 431